Samsara BioCapital, L.P. → Nkarta, Inc. NKTX

Stake: 4.90% Shares: 3,507,666 CUSIP: 65487U108 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 9.61

5,531,075 shares short · +0.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $102K

Point72 Asset Mgmt

Other 13D/G Filings on Nkarta, Inc.

Filed	Form	Filer	Stake	Shares
2021-11-22	SC	Novo Holdings A/S	—	—	view →

Other Filings by Samsara BioCapital, L.P.

Filed	Form	Issuer	Stake	Shares
2026-01-13	SCHEDULE	ALUMIS INC. ALMS	5.40%	6,345,219	view →
2025-09-03	SCHEDULE	vTv Therapeutics Inc. VTVT	9.90%	343,223	view →
2025-03-17	SCHEDULE	Mineralys Therapeutics, Inc. MLYS	9.10%	5,736,305	view →
2024-10-07	SC	Scholar Rock Holding Corp SRRK	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →